figtree know the aussie market well, page-8

Redfaces - I appreciate that you see many of the responses to your posts as a kneejerk reaction by those who only have time for positivity, but I respectfully suggest you could aim for a bit more balance.

You started this thread with a classic 'guilt by association'. It is true that Evgueni Tablis was with Opes Prime in the US, but this fact on its own tells us nothing, and contributes no useful information to a decision regarding PRR.

If you are inferring Evgueni was somehow actively involved in some activity or behaviour that directly led to the downfall of Opes Prime then let us have the facts.

My reading of the Ferrier Hodgson report could find no evidence of this, and therefore the only conclusion I could reach as to why you mentioned his name along with Opes Prime was to infer something negative, and create a sense of caution.

This does suggest that you are not trying to assess Prima objectively, but rather are looking for morsels of information that can be presented in such a way to create doubt.

I would appreciate you either providing evidence that Evgueni Tablis was involved in some unethical or dubious behaviour relating to Opes Prime, or acknowledge that no such evidence does exist, and retract the guilt by association post.

My own personal view is that the most risky part of investing in biomedical stocks is hoping they survive for long enough to realise their potential. Even those with an advanced product can fall over without liquidity (Eg, Ventracor).

We can argue over the fine points of todays announcement, but for me I see it as positive because at a time of ongoing financial instability it gives Prima more time to reach its potential.

We can agree to disagree on whether Prima will ever reach this potential, but at least with this arrangement they have been given an opportunity to do so.

It has been said several times here, but does need to be said again - Prima is a risky play, and may not succeed in getting a product to market. Investors in this company understand this, but are prepared to accept the risk, because if they succeed the reward for patients, the company and shareholders will be significant.

You obviously feel the risk is far greater than I do,and that's OK. You don't invest, and I do, and hopefully neither of us will say 'I told you so' regardless of the eventual outcome, but please, if you are going to post something about the company please make it more useful than guilt by association.